Remarkable progress has been made in the treatment and control of hepatitis B and C viral
infections. However, fundamental treatments for diseases in which liver fibrosis is a key …

Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI)
and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most …

The Billroth III guidelines were developed during a consensus meeting of the Austrian
Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of …

Contrast-enhanced ultrasound (CEUS) is a safe, relatively inexpensive, and widely
available imaging technique using dedicated imaging ultrasound sequences and FDA …

Background Locally advanced hepatocellular carcinoma (HCC) with portal vein tumor
thrombosis (PVTT) has a poor oncological outcome. This study evaluated the oncological …

Although portal vein thrombosis (PVT) commonly occurs in patients with hepatocellular
carcinoma (HCC), the hypercoagulability mechanism in patients with HCC is not entirely …

Aims This study seeks to evaluate the association between pre‐transplant portal vein
thrombosis (PVT) and overall survival, graft failure, waitlist mortality, and post‐operative PVT …

Background Portal vein thrombosis (PVT) is a rare but severe entity that can cause clinically
significant sequela such as worsening portal hypertension or mesenteric ischemia. Those …

Purpose This study aimed to explore inflammatory biomarkers, stool's functional bacterial
groups and their possible link to portal vein thrombosis (PVT) in patients with liver cirrhosis …

Background and aims The role of thrombolytic therapy in patients with portal venous system
thrombosis (PVST) remains ambiguous. This study aimed to systematically collect available …